Preliminary research has demonstrated for the first time that lutein, an important phytonutrient that supports eye health, is the predominant carotenoid present in key areas of the infant brain, including areas that regulate overall brain function, cognition, vision, hearing and speech.

This new research, supported by Abbott, was presented by Elizabeth Johnson, PhD, a scientist in the Carotenoids and Health Laboratory at Tufts University, at the 16th International Symposium on Carotenoids, in Krakow, Poland.

“To our knowledge this is the first time research has been conducted to demonstrate that the infant brain appears to preferentially take up more lutein compared to other carotenoids,” said Dr. Johnson, who led the research with coauthors from Abbott and Tufts University and who is a member of Abbott’s Science Nutrition Advisory Board on the Macular Xanthophylls and DHA. “Additional studies may lead to greater understanding of the functional impact of lutein in infant brains.”

Results from the abstract show lutein concentrations in these important brain regions range from 2.5 to 4 times that of zeaxanthin and 5-6 times that of beta-carotene, depending on the specific brain region. Because lutein is not produced by the body, prior to the introduction of solid foods, infants can only obtain lutein from breast milk or formulas that are fortified with lutein.

At the meeting, Abbott also presented a position statement released by its Science and Nutrition Advisory Board on the Macular Xanthophylls and DHA, which, based on several scientific findings, concluded there is a strong need to study the potential benefits of lutein in cognitive development in infants. This statement is based on lutein research conducted in older adults demonstrating cognitive benefits. For further information: www.abbottnutrition.com